ScoreWhy is Futura Medical Plc ?
1
Poor Management Efficiency with a low ROE of 2.89%
- The company has been able to generate a Return on Equity (avg) of 2.89% signifying low profitability per unit of shareholders funds
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -5.70
- Poor long term growth as Net Sales has grown by an annual rate of 21.98% and Operating profit at -54.05% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -5.70
- The company has been able to generate a Return on Equity (avg) of 2.89% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 21.98% and Operating profit at -54.05% over the last 5 years
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -95.96%, its profits have fallen by -527.1%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Futura Medical Plc for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Futura Medical Plc
-95.96%
-0.75
132.96%
FTSE 100
16.06%
1.36
11.82%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
21.98%
EBIT Growth (5y)
-54.05%
EBIT to Interest (avg)
-5.10
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.74
Sales to Capital Employed (avg)
1.11
Tax Ratio
4.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
0
ROE (avg)
2.89%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.24
EV to EBIT
-0.01
EV to EBITDA
-0.02
EV to Capital Employed
-0.09
EV to Sales
0.05
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-196.34%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at GBP -4.3 MM
RAW MATERIAL COST(Y)
Fallen by -40.79% (YoY
PRE-TAX PROFIT(Q)
At GBP -1.18 MM has Grown at 62.18%
NET PROFIT(Q)
At GBP -1.18 MM has Grown at 60.93%
-1What is not working for the Company
CASH AND EQV(HY)
Lowest at GBP 1.24 MM
Here's what is working for Futura Medical Plc
Operating Cash Flow
Highest at GBP -4.3 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (GBP MM)
Pre-Tax Profit
At GBP -1.18 MM has Grown at 62.18%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (GBP MM)
Net Profit
At GBP -1.18 MM has Grown at 60.93%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (GBP MM)
Raw Material Cost
Fallen by -40.79% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Futura Medical Plc
Cash and Eqv
Lowest at GBP 1.24 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Footer loading
